CI Canadian Convertible Bond ETF Common (CXF) Competitors

Fennec Pharmaceuticals (TSE:FRX) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Does the media prefer FRX or CXF?

In the previous week, Fennec Pharmaceuticals' average media sentiment score of 0.67 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that Fennec Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Fennec Pharmaceuticals	Positive
CI Canadian Convertible Bond ETF Common	Neutral

Do insiders & institutionals have more ownership in FRX or CXF?

52.8% of Fennec Pharmaceuticals shares are owned by institutional investors. 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has preferable valuation and earnings, FRX or CXF?

CI Canadian Convertible Bond ETF Common has lower revenue, but higher earnings than Fennec Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fennec Pharmaceuticals	C$34.86M	5.09	-C$800.44K	-C$0.06	-156.02
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A

Does the MarketBeat Community prefer FRX or CXF?

Fennec Pharmaceuticals received 93 more outperform votes than CI Canadian Convertible Bond ETF Common when rated by MarketBeat users. Likewise, 69.80% of users gave Fennec Pharmaceuticals an outperform vote while only 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote.

Company	Underperform	Outperform
Fennec Pharmaceuticals	Outperform Votes 104 69.80%	Underperform Votes 45 30.20%
CI Canadian Convertible Bond ETF Common	Outperform Votes 11 57.89%	Underperform Votes 8 42.11%

Do analysts rate FRX or CXF?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
CI Canadian Convertible Bond ETF Common	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is FRX or CXF more profitable?

CI Canadian Convertible Bond ETF Common has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -2.30%. Fennec Pharmaceuticals' return on equity of 29.94% beat CI Canadian Convertible Bond ETF Common's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fennec Pharmaceuticals	-2.30%	29.94%	8.88%
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A

Summary

Fennec Pharmaceuticals beats CI Canadian Convertible Bond ETF Common on 10 of the 11 factors compared between the two stocks.